BioSpace News Archive

Career Advice

Career Coach: How to Boost Your Job Application by Networking

Plus, communication errors that cost job offers and how to craft a LinkedIn “About” section

November 14, 2024

·

6 min read

·

Carina Clingman

FDA signage at its headquarters in Maryland

Approvals

PTC Wins First FDA Nod for Direct-to-Brain Gene Therapy, Targets Ultrarare Disease

The FDA has followed in the footsteps of its European counterparts and granted accelerated approval to PTC Therapeutics’ gene therapy Kebilidi for AADC deficiency. It is the first approved gene therapy to be delivered directly to the brain.

November 14, 2024

·

2 min read

·

Tristan Manalac

GSK's headquarters office building in Poznan, Poland

Cancer

GSK Builds Case for Blenrep with Multiple Myeloma OS Data That Bests J&J’s Darzalex

GSK is carving out a niche for Blenrep in the second-line multiple myeloma setting, for which it projects multi-blockbuster potential for the antibody-drug conjugate.

November 14, 2024

·

2 min read

·

Tristan Manalac

Feb 2, 2020 South San Francisco / CA / USA - Merck & Co. headquarters in Silicon Valley; Merck & Co. Inc. is an American multinational pharmaceutical company

Collaboration

Merck Hops Onto PD-1/VEGF Train, Committing up to $3B Plus in LaNova Deal

Despite recent enthusiasm around the PD-1/VEGF space, BMO Capital Markets analyst Evan Seigerman noted that Merck’s pact with LaNova Medicines is more “conservativism” on the pharma’s part than confirmatory of recent data in the drug class.

November 14, 2024

·

2 min read

·

Tristan Manalac

Employee competency assessment. Collage of hands holding king and a pawn. Succession planning.

Cell Therapy

Allogene Bows to BMS in Leukemia, Ending Phase I CAR T Enrollment

Allogene is ceasing enrollment in a Phase I trial of cema-cel for patients with relapsed or refractory chronic lymphocytic leukemia after Bristol Myers Squibb’s Breyanzi was approved in the indication earlier this year.

November 14, 2024

·

1 min read

·

Annalee Armstrong

Art collage, coins, and arrow up on the red and paper background. Concept of business and financial growth.

Cancer

Adaptimmune Plots Path to FDA as Sarcoma Cell Therapy Aces Pivotal Trial

Following strong treatment response data for Adaptimmune’s lete-cel, the biotech is planning to initiate a rolling BLA submission to the FDA, set to start by the end of 2025.

November 14, 2024

·

2 min read

·

Tristan Manalac

Employees Walking In And Out Of The Door, Some Were Leaving Their Job And Some Were Being Hired At The Same Time. Full Length, Isolated On Solid Color Background. Vector, Illustration, Flat Design, Character.

Layoffs

Marinus Pharmaceuticals Lays Off 45% of Employees

The November layoffs are the second known workforce reduction this year for Marinus Pharmaceuticals, which previously announced disappointing Phase III results for ganaxolone in two clinical trials.

November 14, 2024

·

1 min read

·

Angela Gabriel

Press Releases

Fennec Pharmaceuticals to Participate in Upcoming Investor Conference

November 14, 2024

·

1 min read

Press Releases

ARS Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates